Various treatment options are available for pulmonary arterial hypertension (PAH). Medications like prostacyclin analogs, endothelin receptor antagonists, and activin signaling inhibitors help ...

Are you searching for effective medications to treat 'Pulmonary Arterial Hypertension'? This comprehensive guide provides the latest information on medications-both generic and branded-that are ...

Looking for reliable medications to treat 'Pulmonary Hypertension'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Pulmonary arterial hypertension (PAH), defined as a mean pulmonary artery pressure (PAPm) ≥ 25 mm Hg with a pulmonary capillary wedge pressure ≤ 15 mm Hg measured by cardiac catheterization ...

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension.

Aaron Holley, MD, writes that it takes a 'physiologic village' to create activity intolerance after pulmonary embolism, and argues for more use of cardiopulmonary exercise testing to evaluate it.

Evidence is presented that suggests that severe pulmonary arterial hypertension in mitral stenosis is not due entirely to an elevation of pressure in the left auricle but is due, in part ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients helped delay serious outcomes in the ZENITH trial. Among 172 ...

The 6th World Symposium on Pulmonary Hypertension Task Force on hemodynamic ... The Registry to Evaluate Early and Long-Term Pulmonary Arterial Disease Management (REVEAL) was initiated in the ...

Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious condition that can impair blood flow ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

Figure 1: Serine elastase inhibition induces survival by reversal of pulmonary hypertension ... Figure 2: Reversal of pulmonary arterial muscular changes by elastase inhibition.